Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.840
+0.040 (1.43%)
At close: Nov 21, 2024, 4:00 PM
2.880
+0.040 (1.41%)
After-hours: Nov 21, 2024, 6:23 PM EST
Autolus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 756 | 1,120 | 329 | 378 | 468 | 594 | |
Market Cap Growth | 138.69% | 240.67% | -13.12% | -19.06% | -21.26% | -54.96% | |
Enterprise Value | 400 | 1,057 | 233 | 227 | 343 | 391 | |
Last Close Price | 2.84 | 6.44 | 1.90 | 5.19 | 8.94 | 13.20 | |
PS Ratio | 65.33 | 659.69 | 51.70 | 162.42 | 272.63 | 204.18 | |
PB Ratio | 1.58 | 10.05 | 1.10 | 1.21 | 2.23 | 2.33 | |
P/TBV Ratio | 2.03 | 10.05 | 1.10 | 1.21 | 2.23 | 2.33 | |
EV/Sales Ratio | 39.63 | 622.48 | 36.69 | 97.51 | 199.84 | 134.49 | |
Debt / Equity Ratio | 0.63 | 2.01 | 0.50 | 0.22 | 0.26 | 0.10 | |
Asset Turnover | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
Quick Ratio | 12.52 | 5.90 | 8.87 | 11.79 | 5.44 | 9.65 | |
Current Ratio | 13.69 | 6.15 | 9.18 | 12.15 | 5.86 | 9.98 | |
Return on Equity (ROE) | -82.20% | -101.61% | -48.64% | -54.30% | -61.13% | -50.81% | |
Return on Assets (ROA) | -21.61% | -25.35% | -19.94% | -25.07% | -35.16% | -31.82% | |
Return on Capital (ROIC) | -23.14% | -27.98% | -21.52% | -27.18% | -38.55% | -34.54% | |
Earnings Yield | -35.75% | -18.60% | -45.27% | -37.55% | -30.39% | -20.86% | |
FCF Yield | -27.20% | -13.98% | -37.45% | -33.48% | -28.33% | -20.18% | |
Buyback Yield / Dilution | -47.73% | -83.11% | -31.78% | -39.81% | -19.72% | -25.92% | |
Total Shareholder Return | -47.73% | -83.11% | -31.78% | -39.81% | -19.72% | -25.92% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.